| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |